Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $22.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target hoisted by Truist Financial from $21.00 to $22.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price target points to a potential upside of 5.95% from the company’s current price.

Other research analysts also recently issued research reports about the stock. Wall Street Zen downgraded shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Friday, January 23rd. UBS Group increased their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Thursday, February 19th. Citigroup increased their price objective on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, February 18th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $22.00 target price on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. Finally, Cantor Fitzgerald raised their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 17th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $21.90.

Sabra Healthcare REIT Stock Down 0.1%

NASDAQ:SBRA traded down $0.02 during trading hours on Friday, reaching $20.77. 1,067,699 shares of the company traded hands, compared to its average volume of 2,781,832. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. The business’s 50-day moving average price is $19.62 and its two-hundred day moving average price is $19.00. Sabra Healthcare REIT has a 1 year low of $15.75 and a 1 year high of $21.07. The stock has a market capitalization of $5.24 billion, a P/E ratio of 32.48, a P/E/G ratio of 1.66 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.26). The company had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. Sabra Healthcare REIT’s revenue was up 16.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts predict that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in SBRA. Corient Private Wealth LLC purchased a new stake in Sabra Healthcare REIT in the 4th quarter worth approximately $266,000. Hsbc Holdings PLC lifted its holdings in Sabra Healthcare REIT by 19.7% during the fourth quarter. Hsbc Holdings PLC now owns 514,409 shares of the real estate investment trust’s stock valued at $9,738,000 after purchasing an additional 84,784 shares in the last quarter. Beaird Harris Wealth Management LLC bought a new position in shares of Sabra Healthcare REIT in the fourth quarter worth approximately $114,000. Mercer Global Advisors Inc. ADV boosted its position in shares of Sabra Healthcare REIT by 14.4% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 66,869 shares of the real estate investment trust’s stock worth $1,267,000 after purchasing an additional 8,411 shares during the period. Finally, EP Wealth Advisors LLC purchased a new stake in shares of Sabra Healthcare REIT in the fourth quarter worth $300,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.